Global Heart Pump Devices Market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Access Full Report: https://databridgemarketresearch.com/reports/global-heart-pump-device-market/
The global heart pump devices market highly concentrated to a few big players and rest to local players who cater to domestic markets only. Abbott dominated the heart pump devices market accounting for a highest market share in 2017, followed by Getinge AB, Teleflex Incorporated and Abiomed. Other players in this market include are Jarvik Heart, Inc., Berlin Heart, Calon Cardio, CardiacAssist, Inc., Medtronic, ReliantHeart Inc., SynCardia Systems, LLC, Terumo Corporation, Thoratec Corporation among others.
Abbott, founded in 1888 and headquarters in Illinois, U.S., focuses on manufacturing products for diagnostics, medical devices, nutrition and branded generic pharmaceuticals. It operates its business through Established Pharmaceuticals, Nutritionals, Diagnostics, Cardiovascular and Neuromodulation and Others. It offers heart pumps products through its cardiovascular and neuromodulation.
The company has its presence in U.S., China, Germany, Japan, India, The Netherland, Switzerland, Russia, France, Brazil, Italy, U.K., Colombia, Canada, Vietnam and others. It has its subsidiaries worldwide such as Alere Inc. (U.S.), Abbott Medical Optics Inc. (U.S.), EAS (U.S.), Abbott India Ltd (India), Thoratec Corporation (U.S.) and others.
Getinge AB, founded in 1904 and based in Sweden. It is involved in designing, manufacturing and marketing of equipment and systems for healthcare and life sciences. It operates its business through acute care therapies and surgical workflows. It offers heart pump devices through its subsidiary Maquet (Germany). The company has its presence in North America, South America, Asia Pacific, Europe, Middle East and Africa.
Teleflex Incorporated founded in 1943 and headquarters in Korea, focuses manufacturing products for vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. It operates its business in Vascular North America, Interventional North America, Anesthesia North America, Surgical North America, EMEA, Asia, OEM and All other.
The company has its presence in Americas, Europe, Middle East, Africa and Asia Pacific.
Global Heart Pump Devices Market – Industry Trends and Forecast to 2027